SCHEMBL30813475

SCHEMBL30813475

COc1ccc(CNc2ncnc3c2c([Sn](C)(C)C)nn3C2CN(C(=O)OC(C)(C)C)C2)c(OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ SRC P12931 2/20 0.39
▸ CYP1A2 P05177 10/20 0.39
▸ CYP3A4 P08684 10/20 0.39
▸ CYP2C19 P33261 10/20 0.39
▸ CYP2D6 P10635 9/20 0.39
▸ ALDH1A1 P00352 7/20 0.39
▸ CLK4 Q9HAZ1 6/20 0.39
▸ HSD17B10 Q99714 6/20 0.39
▸ MAPK1 P28482 4/20 0.39
▸ LMNA P02545 3/20 0.39
▸ USP2 O75604 3/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ EGFR P00533 1/20 0.39
▸ ABL2 P42684 1/20 0.39
▸ TSHR P16473 7/20 0.39
▸ CYP2C9 P11712 6/20 0.39
▸ CCRL2 O00421 1/20 0.38
▸ EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27217814 1.00 RET (0.40) RETKDRSRCCYP1A2CYP3A4
SCHEMBL27217885 0.94 BTK (0.45) SRCABL1EGFRABL2EPHX2
SCHEMBL27217837 0.93 EPHX2 (0.43) RETKDRSRCCYP3A4ALDH1A1
SCHEMBL30813648 0.93 EPHX2 (0.43) RETKDRSRCCYP3A4ALDH1A1
SCHEMBL30813465 0.90 RET (0.40) RETKDRSRCCYP1A2CYP3A4
SCHEMBL27217888 0.85 CYP1A2 (0.45) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL27217936 0.83 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL30813667 0.83 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL30813541 0.83 BTK (0.46) SRCABL1EGFRABL2PDE9A
SCHEMBL30813419 0.83 EPHX2 (0.44) RETKDRSRCCYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059200-A1 NEK7 INHIBITORS Halia Therapeutics, Inc. (US) 2024-03-21 — — WO disclosed
Send feedback